Correction: Exploring a New Entity of Single-Agent Pembrolizumab-Associated Hypophysitis
Cureus
.
2024 Mar 20;16(3):c166.
doi: 10.7759/cureus.c166.
eCollection 2024 Mar.
Authors
Eric Balti
1
,
Sarah Verhaeghe
1
,
Vibeke Kruse
2
3
4
,
Stijn Roels
5
,
Peter Coremans
1
Affiliations
1
Department of Endocrinology and Diabetes, VITAZ Hospital, Sint-Niklaas, BEL.
2
Department of Medical Oncology, VITAZ Hospital, Sint-Niklaas, BEL.
3
Department of Molecular Imaging, Pathology, Radiotherapy and Oncology (MIPRO), University of Antwerp, Wilrijk, BEL.
4
Department of Oncology, Antwerp University Hospital, Edegem, BEL.
5
Department of Radiology, VITAZ Hospital, Sint-Niklaas, BEL.
PMID:
38516288
PMCID:
PMC10955672
DOI:
10.7759/cureus.c166
Abstract
[This corrects the article DOI: 10.7759/cureus.27763.].
Copyright © 2024, Balti et al.
Publication types
Published Erratum